amphetamine has been researched along with Brain Diseases in 20 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Schizophrenia is a neuropsychiatric disorder of a neurodevelopmental origin manifested symptomatically after puberty." | 5.35 | Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. ( Assaf, Y; Piontkewitz, Y; Weiner, I, 2009) |
| "Schizophrenia is a neuropsychiatric disorder of a neurodevelopmental origin manifested symptomatically after puberty." | 1.35 | Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. ( Assaf, Y; Piontkewitz, Y; Weiner, I, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanemaru, K | 1 |
| Kinouchi, H | 1 |
| Yoshioka, H | 1 |
| Yagi, T | 1 |
| Wakai, T | 1 |
| Hashimoto, K | 1 |
| Fukumoto, Y | 1 |
| Umeda, T | 1 |
| Onishi, H | 1 |
| Nishiyama, Y | 1 |
| Horikoshi, T | 1 |
| Piontkewitz, Y | 1 |
| Assaf, Y | 1 |
| Weiner, I | 1 |
| Olds, ME | 1 |
| Jacques, DB | 1 |
| Kpoyov, O | 1 |
| CLANCY, J | 1 |
| Moroz, IA | 1 |
| Peciña, S | 1 |
| Schallert, T | 1 |
| Stewart, J | 1 |
| Ouagazzal, A | 1 |
| Nieoullon, A | 1 |
| Amalric, M | 1 |
| Sziráki, I | 1 |
| Kardos, V | 1 |
| Patthy, M | 1 |
| Pátfalusi, M | 1 |
| Budai, G | 1 |
| Chambers, RA | 1 |
| Moore, J | 1 |
| McEvoy, JP | 1 |
| Levin, ED | 1 |
| Balse, E | 1 |
| Suhr, R | 1 |
| Haaf, A | 1 |
| Kelche, C | 1 |
| Jackisch, R | 1 |
| Cassel, JC | 1 |
| Joseph, MH | 1 |
| Peters, SL | 1 |
| Moran, PM | 1 |
| Grigoryan, GA | 1 |
| Young, AM | 1 |
| Gray, JA | 1 |
| Leviel, V | 1 |
| Siever, L | 1 |
| Kraemer, H | 1 |
| Sack, R | 1 |
| Angwin, P | 1 |
| Berger, P | 1 |
| Zarcone, V | 1 |
| Barchas, J | 1 |
| Brodie, HK | 1 |
| Kolarík, J | 1 |
| Pĕnicková, V | 1 |
| Ohta, H | 1 |
| Komibuchi, T | 1 |
| Nishino, I | 1 |
| Enomoto, Y | 1 |
| Miyata, M | 1 |
| Castañeda, E | 1 |
| Whishaw, IQ | 1 |
| Robinson, TE | 1 |
| Meloni, R | 1 |
| Gale, K | 1 |
| Tennant, FS | 1 |
| Swendseid, ME | 1 |
| Shogam, II | 1 |
| Jovanović, UJ | 1 |
| Crighel, E | 1 |
| Poilici, I | 1 |
1 review available for amphetamine and Brain Diseases
| Article | Year |
|---|---|
The reverse transport of DA, what physiological significance?
Topics: Amphetamine; Animals; Biological Transport, Active; Brain Diseases; Brain Ischemia; Corpus Striatum; | 2001 |
19 other studies available for amphetamine and Brain Diseases
| Article | Year |
|---|---|
Cerebral hemodynamic disturbance in dural arteriovenous fistula with retrograde leptomeningeal venous drainage: a prospective study using (123)I-iodoamphetamine single photon emission computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Amphetamine; Brain Diseases; Central Nervous System Vascular Malform | 2015 |
Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
Topics: Abnormalities, Drug-Induced; Age Factors; Amphetamine; Animals; Antipsychotic Agents; Attention; Bra | 2009 |
Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
Topics: Amphetamine; Animals; Apomorphine; Brain Diseases; Brain Tissue Transplantation; Corpus Striatum; Do | 2003 |
OTHER ASPECTS OF DEPRESSION.
Topics: Alcoholism; Amphetamine; Antidepressive Agents; Barbiturates; Bipolar Disorder; Brain Diseases; Depr | 1965 |
Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Behav | 2004 |
Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Topics: Amphetamine; Animals; Brain; Brain Diseases; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamin | 1994 |
Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Bra | 1994 |
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Diseases; Central Nervous System Stimulants; Disease M | 1996 |
The potentiation of amphetamine-induced hyperlocomotion by fimbria-fornix lesions in rats is abolished by intrahippocampal grafts rich in serotonergic neurons.
Topics: Amphetamine; Animals; Brain Diseases; Choline; Drug Synergism; Electric Stimulation; Female; Frontal | 1999 |
Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning.
Topics: Amphetamine; Animals; Association Learning; Behavior, Animal; Brain Diseases; Conditioning, Psycholo | 2000 |
Gradients of biogenic amine metabolites in cerebrospinal fluid.
Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma | 1975 |
A contribution to the electrogenesis of distant rhythms in EEG.
Topics: Amphetamine; Brain; Brain Diseases; Cerebellar Neoplasms; Electroencephalography; Epilepsy; Humans; | 1975 |
Brain perfusion abnormalities in a thinner and amphetamine abuser detected by I-123 IMP scintigraphy.
Topics: Adult; Amphetamine; Amphetamines; Brain Diseases; Electroencephalography; Humans; Iodine Radioisotop | 1992 |
Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dialysis; Dop | 1990 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; C | 1991 |
Alterations in catecholamine metabolism partially corrected during amphetamine-dependence.
Topics: Adult; Amphetamine; Brain Diseases; Catecholamines; Female; Humans; Neurocognitive Disorders; Self M | 1985 |
[A study of sensation by the double simultaneous stimulation method].
Topics: Adult; Amphetamine; Brain Diseases; Caffeine; Epinephrine; Female; Humans; Hypesthesia; Methods; Pai | 1974 |
[Subclinical sleep activity in the EEG].
Topics: Adult; Amphetamine; Arousal; Brain Diseases; Cataplexy; Child; Child Behavior Disorders; Electroence | 1969 |
Photic evoked responses in patients with thalamic and brain stem lesions.
Topics: Adult; Aged; Amphetamine; Blindness; Blood Pressure; Brain Diseases; Brain Stem; Cerebral Cortex; El | 1968 |